Pooled human immunoglobulins contain anti-idiotypes with reactivity against the SLE-associated 4B4 cross-reactive idiotype

Clinical and Experimental Rheumatology

Volumn 14, Issue 6, 1996, Pages 587-591

  DeKeyser, F ^a   DeKeyser, H ^a   Kazatchkine, M D ^b   Rossi, F ^b   Dang, H ^a   Talal, N ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

idiotype; Sm nucleoprotein; systemic lupus erythematosus

Indexed keywords

IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULINS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RABBITS;

EID: 0030470823     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BERKMAN SA, LEE ML, GALE RP: Clinical use of intravenous immunoglobulins. Ann Intern Med 1990; 112: 278-92.
2. SCHWARTZ SA: Intravenous immunoglobulin for the therapy of autoimmune disorders. J Clin Immunol 1990; 10: 81-9.
3. ONCLEY JL, SCATCHARD G. BROWN A: Physical-chemical characteristics of certain of the protein of normal human plasma. J Phys Coll Chem 1947; 51: 184-98.
4. JAMES K, HENNEY CS, STANWORTH DR: Structural changes occuring in 7S gammaglobulins. Nature 1964; 202: 563-6.
5. STANWORTH DR, HENNEY CS: Some biological activities associated with the 10S form of human gammaG-globulin. Immunol 1967; 12: 267-74.
6. HANSSON UB: Aggregation of immunoglobulin G upon freezing, Acta Chem Scand 1968; 22: 483-9.
7. MACKAY M, VALLET L, COMBRIDGE BS: The characterization and stability during storage of human immunoglobulin prepared for clinical use. Vox Sang 1973; 25: 124-40.
8. TANKERLEY DL, PRESTON MS, FINLAYSON JS: Immunoglobulin G dimer: an idiotype-anti-idiotype complex. Mol Immunol 1988, 25:41-8.
9. LUNDKVIST I, VAN DOORN PA, VERMEULEN M, VAN LINT M, VAN ROOD JJ, BRAND A: Regulation of autoantibodies in inflammatory demyelinating polyneuropathies-spontaneous and therapeutic. Immunol Rev 1989; 110: 105-17.
10. ZOUALI M, EYQUEM A: Expression of anti-idiotypic clones against auto-anti-DNA antibodies in normal individuals. Cell Immunol 1983; 76: 137-47.
11. 2 antibodies in relatives of patients with systemic lupus erythematosus. Clin Exp Immunol 1985; 60: 329-38.
12. ROSSI F, DIETRICH G, KAZATCHKINE MD: Anti-idiotypes against autoantibodies in normal immunoglobulins. Evidence for network regulation of human autoimmune responses. Immunol Rev 1989; 110: 135-49.
13. DIETRICH G, KAZATCHKINE MD: Normal immunoglobulin G for therapeutic use contain anti-idiotypic specificities against immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest 1990; 85: 620-5.
14. SHOENFELD YS, HSU-LIN SC, GABRIELS JE, SILBERSTEIN LE, FURIE BC, FURIE B, STOLLAR BD, SCHWARTZ RS: Production of autoantibodies by human-human hybridomas. J Clin Invest 1982; 70: 205-9.
15. TAKEI M, DANG H, WANG RJ, TALAL N: Characteristics of a human monoclonal anti-Sm autoantibody expressing an interspecies idiotype. J Immunol 1988; 140: 3108-13.
16. TAKEI M, DANG H, TALAL N: A common idiotype expressed on a murine anti-Sm monoclonal antibody and antibodies in SLE sera. Clin Exp Immunol 1987; 70: 546-54.
17. DANG H, OGAWA N, TAKEI M, LAZARIDIS K, TALAL N: Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a crossreactive idiotype 4B4. J Immunol 1993; 151: 7260-7.
18. NEU HC, HEPPEL HH: The release of enzymes from E. coli by osmotic shock and during formation of spheroplasts. J Biol Chem 1965; 240: 3685-92.
19. MEEK K, TAKEI M, DANG H, SANZ I, DAUPHINEE MJ, CAPRA JD, TALAL N: Antipeptide antibodies detect a lupusrelated interspecies idiotype that maps to H chain CDR2. J Immunol 1990; 144: 1375-81.
20. DWYER JM: Manipulating the immune system with immune globulin. N Engl J Med 1992; 326: 107-16.
21. MAIER WP, GORDON DS, HOWARD RF, SALEH MN, MILLER SB, LIEBERMAN JD, WOODLEE PM: Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia. Arthritis Rheum 1990; 33: 1233-9.
22. FRANCIONI C, GALEAZZI M, FIORAVANTI A, GELLI R, MEGALE F, MARCOLONGO R: Long term I.V. Ig treatment in systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12: 163-8.
23. KRAUSE I, BLANK M, KOPOLOVIC J, AFEK A, GOLDBERG I, TOMER Y, SHOENFELD Y: Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gammaglobulin J Rheumatol 1995; 22: 1068-74.
24. JUNGI TW, BRCIC M, KUHNERT P, SPYCHER MO, LI F, NYDEGGER UE: Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes. Clin Exp Immunol 1990; 82: 163-9.
25. DELFRAISSY JF, TCHERNIA G YL, WALLON C, GALANAUD P, DORMANT J: Suppressor cell function after intravenous gammaglobulin treatment in adult idiopathic thrombocyto-penic purpura. Br J Haematol 1985; 60: 315-22.
26. ANDERSSON U, BJÖRK L, SKANSEN S, ANDERSSON J: Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev 1994; 139: 21-42.
27. KAZATCHKINE MD, DIETRICH G, HUREZ V, RONDA N, BELLON B, ROSSI F, KAVERI SV: V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig). Immunol Rev 1994; 139: 79-108.